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Chapter 11

OVARIAN TUMORS IN CHILDREN
AND ADOLESCENTS
Linah Al-Alem, MSc, Amit M. Deokar, MD, MPH,
Rebecca Timme, MD and Hatim A Omar* MD

Adolescent Medicine and Young Parent Programs, J422 Kentucky
Clinic, Department of Pediatrics, Kentucky Children's Hospital,
University of Kentucky College of Medicine, Lexington, Kentucky,
United States of America

Ovarian tumors are uncommon in the child and adolescent
population, but given that cancer is a leading cause of death even in
this age group it is important for the general practice physician to be
aware of the signs and symptoms. These can include abdominal
pain, increased abdominal girth, a palpable mass on pelvic or
abdominal exam, nausea and vomiting, decreased appetite, weight
loss. constipation. back pain, leg cramps, dyspareunia, urinary
symptoms, abnormal uterine bleeding, and ascites, to name a few .
* Correspondence; Professor Hatim A Omar, MD. PAAP,
Director of Adolescent Medicine and Young Parent programs, J422 Kentucky Clinic,
Department of Pediatrics, Kentucky Children's Hospital, University of Kentucky
College of Medicine,
Lexington, KY 40536 United States.
Tel: 859-323-6426 ext. 311: Fax. 859-257-7706; E-mail: haomar2@uky.edu
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The types of gynecological tumors seen in adults are also seen in
children except in differing frequencies. The most common type of
ovarian tumor in children is the germ cell tumor, of which there are
several subtypes including dem1oid cysts, dysgerminoma, yolk sac
tumor, immature teratomas, and embryonal carcinomas.

INTRODUCTION
Ovarian tumors in children and adolescents are the most common genital
neoplasms ( 1 ) . In fact, ovarian rumors account for 1% of all neoplasms in
girls under the age of 17 (1) and although ovarian tumors are relatively
rare, they comprise about 70% of all childhood gynecological
malignancies (2). Overall, ovarian cancer claims the lives of 8.8 women
per 100,000 women in the total population (3). Ovarian tumors are
diverse in origin, progression and treatment. All types of ovarian tumors
that are seen in adults are also seen in children but their incidence is
different (4). The most common types of ovarian tumors in adolescents
are the functional non-neoplastic types and germ cell tumors (4,5). This
is different from the adult population, where the majority of neoplasms
are ovarian epithelial tumors (6,7). In addition, only 10% of the ovarian
tumors occurring in adolescents are actually malignant (8). Nevertheless,
cancer is a leading cause of death in the adolescent age group, after
accidents and injuries, homicides and suicides (8). History taking and
physical examination are the hallmarks of ovarian tumor diagnosis and
treatment in the adolescent population. This is of extreme importance in
order to ensure a healthy future (4). Unfortunately, ovarian neoplasm
diagnosis is still a problem in today's clinics due to the vague symptoms
with which the patient presents (3). This chapter aims to discuss the
different ovarian tumors as well as their management focusing on the
pediatric and adolescent population.

TYPES OF OVARIAN TUMORS
'There are six main categories of primary ovarian tumors, namely:
Functional cysts, benign ovarian tumors, borderline tumors, neoplasms of
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germ cell origin (germ cell tumors), celomic (epithelial) origin tumors
(epithelial ovarian cancer) and virilizing tumors. This classification is
based on the present day concept of development and structure of the
ovary (9). Other organizations, such as the WHO (World Health
Organization), classify ovarian neoplasms into nine main categories and 26
subtypes. In this chapter we will be discussing the major six types of
ovarian tumors that may be seen by the primary care provider. Usually
after the primary finding of a tumor., the patient is usually referred to a
gynecologic oncologist (1).

EPIDEMIOLOGY
The incidence o f gonadal tumors in general increases with the onset of
puberty. The incidence of all germ cell tumors, the most common type of
ovarian tumors in children, is about 0.6-0.9 per 100,000 children. It is
worthy to note that 25% of all pediatric germ cell tumors present as
tumors with more than one histological type (10). Nevertheless, this
varies significantly according to sex and age. As for the incidence of
ovarian cancer, it tends to rise with age peaking in the eighth decade, and
therefore rarely seen in the adolescent population (10). The majority of
ovarian cancers are the result of sporadic mutations; approximately 10%
are attributed to familial disposition. Females carrying deletions in the
BRCA 1 and BRCA2 genes (tumor suppressor genes) make up the largest
subset risk for ovarian cancer. These deletions are inherited in an
autosomal dominant mode (10). Focusing on 76 subjects under 20 years
of age with ovarian neoplasm, one report found that 63% had germ cell
etiology (11). Thus, although the general incidence of ovarian tumors in
the adolescent population is low, it does occur and early diagnosis is vital
to ensure better survival as well as a better quality of life. What follows
is a discussion of the 6 different subtypes of ovarian tumors.
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CLINICAL PRESENTATIONS
It is of vital importance that primary care providers are aware of the
different ways in which children and adolescents can present clinically.
In contrast, older women may be asymptomatic. The symptoms of an
individual ovarian mass are mentioned in the respective sections. Below
is a list of symptoms that may mimic conditions such as appendicitis,
urinary tract infections, gastroenteritis, sexually transmitted disease and
constipation (12). This list of symptoms will help the provider decrease
the probability of misdiagnosing ovarian tumor. They include the
following:

1. Abdominal pain
This is a fairly consistent symptom in girls under the age of 10 years
(13). It also is the main complaint in all adolescents (14). Occasionally
there may be pressure symptoms in the abdomen or pelvis. Localization
of the pain may depend largely on the age and development of the girl
and is generally higher in the abdominal area due to the relative superior
location of the ovary in young girls. Some children can present with an
acute abdomen and surgical exploration is warranted in cases of adnexal
torsion. Imaging is often helpful in aiding and confirming the
diagnosis(15). It is very crucial for the provider to be aware of other
acu1e situations such as appendicitis, but at the same time remember that
ovary-related pain may mimic such presentation(12).

2. Increased abdominal girth and palpable mass
This could be fixed or nodular. The mass could also be bilateral (14-16).
Palpating the mass can be challenging in an overweight individual.
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3. Other symptoms includes (12-15):
•
•
•
•
•
•
•
•
•
•

•
•
•
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Nausea and vomiting
Decreased appetite
Loss of weight
Constipation
Back pain
Leg cramps
Isosexual precocious pseudopuberty (15)
Dyspareunia
Urinary symptoms such as, urgency, dysuria, etc.
Menstrual abnormalities like abnormal uterine bleeding (AUB),
amenorrhea/oligomenorrhea, menorrhagia, and dysmenorrhea
Ascites
Hydrothorax and difficulty breathing
Virilization

4. Rare presentation(s):
•
•

Thrombocytosis. especially with malignant tumors (17)
Extranodal non-Hodgkin's lymphoma may present as an ovarian
mass (18)

A. OVARIAN FUNCTIONAL CYSTS

Ovarian functional cysts are also known as benign cysts, simple cysts or
physiological cysts. Functional cysts as well as benign neoplasms
(discussed later on) are the most common ovarian masses among young
adolescents (19). The etiology of functional cysts changes with each
stage of development due to hormonal changes (20). In general,
functional ovarian cysts arc mostly non-neoplastic in nature and can be
of a follicular, luteal or pregnancy-related luteoma. A functional cyst
usually occurs in about 7.8% of reproductive aged women (9) and are the
most common lesions in the pediatric age range (21). Functional cysts
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occur due to an exaggerated cyclic ovarian function. Thus, most
functional cysts resolve in a short period of time, usually within one or
two cycles or put differently, 6 to 10 weeks (9) without treatment (20). If
the cyst persists, the diagnosis should remain in question as potentially
neoplastic in nature particularly if the patient has symptoms (20). Some
reports consider lesions that are more than 10 cm as potentially
neoplastic, while those that are less than 5 cm as non-neoplastic (9). It
should be noted that all functional cyst subtypes are usually benign (22).
Ovarian functional cysts are usually unilateral but may occur bilaterally
(1).

Risk factors
The use of progestin only contraceptives may increase the risk of ovarian
tumor development (9). But in general, the use of mixed (progestin and
estrogen) oral contraceptives early acts as a protective agent against
ovarian functional cysts (23). The development of functional cyst
malignancies are more prominent in pre-pubertal girls especially if
ascites is detected (9). Possible complications that may occur post cyst
formation include cyst rupture, intracystic hemorrhage, ovarian torsion
and necrosis (1).

Subtypes of ovarian functional cysts
Follicular origin

These cysts form as a result of anovulation . The follicle starts
accumulatin g cystic fluid, rendering it larger than 25-30 mm when
inspected with an ultrasound. Cysts should only be named 'functional
cysts' when they are 5-10 cm in size. This is due to the notion that
follicles can normally reach 5 cm (9). Most of the time, functional cysts
resolve on their own (20).
Luteal origin
These cyst usually occur during the luteal phase. A patient may present
to the clinic with severe acute pain, which may be due to a ruptured cyst.
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Ruptured cysts may cause intraperitoneal bleeding or an unruptured cyst
causing bleeding into the cyst cavity (hemorrhagic cyst). Functional cysts
of luteal origin appear sponge like upon ultra sound inspection. In fact,
they may even be confused with the development of ectopic pregnancies
(9). Thus, when an ectopic pregnancy is suspected, functional cysts of
luteal origin should be eliminated.
Pregnancy-related luteoma
This subtype of functional cysts is rare and is often asymptomatic. It is
usually seen in adolescents that are pregnant and undergoing cesarean
deliveries. These cysts are usually larger than 20 cm in diameter. In 50%
of the cases presenting with pregnancy-related luteoma, female fetal
masculinization is seen (9).

Symptoms
In general. functional cysts may cause acute pain, pressure, dull or achy
pain that is often present for several weeks especially when the cyst is
large, torsed or ruptured (9). It should also be noted that patients could be
asymptomatic, particularly those that are of a pregnancy-related luteoma.
Other symptoms that the patient may present with are complaints of pain
during bowel movements or intercourse. In some cases, patients may
complains of changes in menstruation (Irregular, longer, or shorter
periods) (9).

Diagnosis
Ultrasonography is usually utilized to localize ovarian lesions but cannot
be used to determine whether these lesions are malignant or not (21).
Histological analysis is needed in order to determine the pathology of the
cyst. Thus, ultrasound is the most common imaging used in making a
functional cyst diagnosis, while MRI is rarely used (9). Pelvic exams are
also helpful in view of the fact that it might indicate a palpable mass. This
depend s on the size of the cyst and the patient weight. An
abdominal exam may reveal tenderness or rebound (9). Several lab tests
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may be performed such as CA-125 (Cancer Anligen 125). It is important
to note that CA 125 in adolescents may not help in distinguishing benign
from malignant cysts and thus, although it may be helpful in some cases,
it is not helpful in most cases. The most important lab test is human
chorionic gonadotropin (?-HCG), which would indicate pregnancy but
can be also be elevated in some tumors. In pregnancy-related lutcomas,
testosterone and AFP (Alpha Feto Protein) can be elevated (9).

Other conditions causing similar symptoms
There are several medical conditions that usually present to the clinician
with identical symptoms. These conditions should be eliminated before a
functional cyst diagnosis is reached. These include conditions such as:
PCOS (polycystic ovarian syndrome), endometriomas, ectopic
pregnancies, appendicitis, other ovarian tumors (dermoid cysts,
mucinous, serous cystadenomas, Fallopian tube carcinomas), PID (pelvic
inflammatory disease) and hyperthecosis (9).

Treatment
Functional cysts tend to resolve on their own (20), and although oral
contraceptive pills are often used, some state that combination oral
contraceptives do not accelerate the regression of these cysts (9,23). In
general, surgical procedures are not done unless absolutely necessary and
should spare the ovary as much as possible (20). If functional cysts of
follicular origin are the diagnosis, the follicle should be monitored for 12 cycles. Functional cysts should regress and become smaller with time
and if they persist, surgery may be considered (9). If the patient presents
with acute pain, the clinician should consider timing the pain with
ultrasound images and characteristics to attempt to correlate the two. In
addition, the clinician should consider the possibility of cystic rupture.
Corpus luteum pain symptoms are usually treated with analgesics or
narcotics although one should be careful with prescribing narcotic
analgesics to adolescents for obvious reasons. This pain management
would give the patient relief from the pain allowing the patient to be
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monitored for 6 weeks. If after 6 weeks the cyst is enlarging or persistent
then this might indicate malignancy of the cyst (9). Laparoscopy is the
most common approach if the functional cyst is persistent (20). This
approach is used in dermoid cysts, which will be discussed later (9). It
should be noted that if the adolescent is pregnant, this will probably
cause an added complexity in trying to differentiate between malignant
and benign cysts (9). Surgery should be avoided as much as possible and
is only used in enlarged or persistent cysts after a minimum of two cycles
(9;23). Pregnancy luteomas have been shown to resolve on their own
after delivery (9).

Follow-up
The rate of malignancy is very low in functional cysts (l). However, if
malignancy is suspected, refe1Tal to an oncologist .is necessary. In order
to prevent future functional cyst formation, oral contraceptives may be
used. Regular pelvic exams are usually used to monitor patients but
repeated ultrasound imaging is not usually indicated (9).

B . BENIGN OVARIAN TUMORS
Benign ovarian masses are rare in the pediatric and adolescent population
unless they are benign functional cysts. The incidence of benign tumors
is not very accurate, but 2/3 of these benign tumors occur in 20-44 year
old patients. Thus, the incidence in the pediatric and adolescent
population is very low (9). Benign ovarian tumors are also known as
ovarian cysts, tumor masses or adnexal masses. These tumors are often
common in patients of reproductive age. Of all ovarian tumors, benign
tumors account for 80-85%. The prognosis for benign ovarian tumors is
often excellent.
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Risk factors
Smoking in the adolescent population increases the risk of developing
benign ovarian tumors by about three fold. Another risk factor is obesity.
In contrast, pregnancy is associated i1wersely to ovarian tumor
development. It should be noted that the presence of a benign ovarian
tumor serves as a risk factor for the development of ovarian cancer
lacer in life (9). Hence, it is necessary to follow up patients into their
adulthood or inform them of their future risk.

Subtypes of benign ovarian tumors
Functional cysts
These usually do not require surgery and arc asymptomatic and benign.
Please refer to Function Ovarian cyst section for more information.
Benign tumors do not have any staging system.
Endometriosis
These are also known as 'chocolate cysts' andoften develop when the patient is
diagnosed with endometriosis (9).
Benign cystic teratomas
These are also known as dermoid cysts and are considered benign germ
cell tumors which are the most. common tumors in adolescents and in
fact, account for about 60% of neoplasms inwomen under 40 years (9).
Epithelial tumors
There are two main types of epithelial ovarian tumors. These are: serous
and mucinous. Other epithelial benign tumors include endometriod.
clear cell, Brenner mixed epithelial and fibromas. Serous tumors are
often benign but in 5-10% of the cases may present as borderline ovarian
tumors and in 20-25% are malignant. Mucinous tumors in turn may
become very large hut only 5-10% are malignant in nature.
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Symptoms
Ovarian tumors are usually asymptomatic but when symptoms are
present they are often nonspecific, mimicking gastrointestinal complaints
such as nausea, vomiting, bloating, constipation, and indigestion. In
addition, urinary urgency, increased abdominal girth fatigue and weight
loss or weight gain are also common. Ovarian torsion is sometimes seen
when acute pain is a patients' chief complaint. Pelvic pain, menstrual
irregularities 1nay be present as well.

Diagnosis
A detailed history should be taken in order to assess familial risk, A
breast exam is necessary since a history or presence of breast cancer is a
risk for the development of ovarian rumors. Abdominal exams should
test for the presence of ascites, a palpable mass or hepatomegaly, which
would suggest the presence of an ovarian tumor. A pelvic exam is
usually used to detect the presence of pelvic tenderness. Also, a pelvic
mass with a size larger than 8-10 cm would suggest the presence of a
neoplasm. Benign tumor diagnosis is done after surgical biopsy of the
tumor and a histological exam. Nevertheless, a benign tumor does nor
usually lead to the accumulation of ascites nor peritoneal tumor studding.
The precise basis and origin of ovarian epithelial tumors is still unknown
(9). Ovarian torsion usually occurs in benign ovarian tumors but not
malignant ones. There are several lab tests that can be performed to help
rule out tumors. The most sensitive exams to detect ovarian tumors
include: ultrasound, MRI, and CT. In contrast, the most specific exams
that can be done include: Bimanual exams, MRI, PET scans (9). CA-125
is rarely used in premenopausal conditions and is not helpful in benign
cases. A serum beta·HCG should always be done in order to rule out
pregnancy.
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Other conditions causing similar symptoms
Several other medical conditions may present in the clinic that have
similar symptoms to the presence of ovarian rumors. These include
PCOS, infections, ovarian malignancy, fallopian tube malignancy,
functional cysts, and other gynecological conditions such as peritoneal
cysts, uterine fibroid, and paraovarian cysts (9).

Treatment
Patients should undergo a period of 6-8 weeks of close monitoring if the
results of ultrasound and MRI are benign. Surgery is only done as a last
resort and several factors should be taken into consideration such as age,
pain, and growth persistence over time. Surgery may be done in cases of
ovarian torsion and masses that do not resolve over time. Oral
contraceptives are used to inhibit ovulation and thus may help prevent
the development of non-neoplastic. In the case of benign cystfo
teratomas, a cystectomy may be done in order to remove the cyst but
preserve the ovary. If there are solid masses, surgical approaches should
be followed by pelvic washings to prevent the risks of tumor cell
spreading. Pathological exams should be performed in order to determine
whether the tumor is for sure benign or not. If the tumor biopsy shows
the presence of borderline or malignant rumors, refer to a gynecological
oncologist (9).

Follow-up
Patients should be monitored with regular pelvic exams and if there are
any abnormalities, ultrasound imaging should be used (9).
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C. BORDERLINE OVARIAN TUMORS
Most borderline tumors occur in women between the ages of 30 and 50
years. Thus, borderline tumors are rare in adolescents. This type of
ovarian tumor accounts for 15% of all ovarian malignancies and usually
occurs 10-20 years prior to the development of ova rian cancer.
Borderline ovarian tumors undergo a less aggressive course than
malignant forms, although it should be noted that it has the potential to
metastasize and reoccur after years of tumor-free status. Borderline
ovarian tumors are also known as low malignant potential (LMP) tumors.

Risk factors
Unlike other ovarian tumors, borderline ovarian tumors are not affected
by smoking, oral contraceptive use, nor BRCA-1 or BRCA-2 mutations.
A family history of ovarian cancer also does not affect the risk of
developing ovarian cancer. One major risk factor is nulliparity (9).

Subtypes of borderline ovarian tumors
About 65% of borderline ovarian tumors have a serous histological type
while 30% are mucinous. The remaining 5% account for the remaining
four subtypes: Endometrioid, clear cell, Brenner cell and mixed. Tumor
cells can spread by various methods including implantation in the
peritoneal cavity or by the lymph system to pelvic lymph nodes and
eventually 10 other organs. Borderline ovarian tumors should be staged
after excision using the International Federation of Gynecological
Oncologists (FIGO).
Stage 1: The tumor is confined to the ovaries
1A: tumor growth is limited to one ovary without any malignant
ascites
1B: tumor growth is limited to two ovaries without any malignant
ascites
1C: tumor or stage 1A or 1B, but with ascites or ruptured capsules
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Stage 2: The tumor has spread to the pelvis
2A: metastasis to the fallopian tubes or uterus
2B: both ovaries affected and extended to the pelvis
2C: a tumor of stage 2A or 2B, but with ascites
Stage 3: There are tumor seeds in the abdominal cavity or
retroperitoneal lymph nodes
3A: confined to the pelvis
3B: metastasis to the peritoneal cavity but not >2cm mass
3C: metastasis to the peritoneal cavity but >2cm mass
Stage 4:Metastasis into other distant organs

Symptoms
Major patient complaints include abdominal pain, constipation, bloating,
nausea, weight changes, decreased appetite, dysuria and irregular
menses.

Diagnosis
Physical exams often reveal solid or fixed masses and ascites or palpable
mass upon abdominal exam. A CA-125 test should not be used in
Borderline ovarian tumors since it is sometimes elevated in benign
conditions, especially in pre-menopausal women with diseases such as
pelvic inflammatory disease, endometriosis and liver disease. In order to
distinguish between malignant and benign tumors, pelvic ultrasound and
CT scans are often used. The presence of persistent pelvic mass upon
serial imaging sessions, a mass larger than 8 cm, solid components,
increased vascularity and bilateral ovarian involvements indicate a
possible malignant tumor rather than borderline ovarian tumor.
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Other conditions causing similar symptoms
Infections such as tubo-ovarian abscess may result in symptoms that
mimic Borderline ovarian tumors. Benign, malignant and metastatic
gynecological neoplasm also may be misdiagnosed as Borderline ovarian
tumors. Other conditions include the presence of pelvic kidney (9).
Treatment
Treatments of Borderline ova1ian tumors involve surgical removal of all
visible masses. Chemotherapy is rarely beneficial due to the
decrease/slow growth rate of this type of tumor. Surgery is typically
used for diagnosis and treatment in this type of ovarian tumor. After
tumor excision, proper staging is required by a gynecologic oncologist in
order to ensure that all the mass is removed. The best removal is a total
hysterectomy, although this should be done with care and only when the
patient does not desire fertility. If histological analysis shows that the
Borderline ovarian tumor is of mucinous origin, an appendectomy should
also be performed. This is necessary due to the possible concomitant
involvement of the appendix with the development of mucinous tumors.
In reoccurrcnce cases, additional surgical excisions are done (9).

Follow-up
If the tumor is confined to the ovary and the surgery was successful no
further surgical interventions arc needed. The patient should be referred
to a gynecologic oncologist for monitoring and to determine whether any
other treatment would be helpful. There is a chance of reoccurrence,
particularly after 10-15 years. Usually survival rates are about 99% for
ovarian borderline tumors diagnosed at stage l or 2. Five and twenty year
survival rares drop to 90% and 45%, respectively at later stages. Thus,
diagnosis at earlier stages is essential. About 6% of the cases could
develop into a low grade serous carcinoma. A physical exam and CA125 is needed every three months for two years and imaging every six
months for two years.
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D.GERM CELL OVARIAN TUMORS
This type of ovarian tumor is the most common ovarian tumor in
adolescents and young women (9, 24). The median age range is 16-20
years old but may occur in patients who are much younger, in fact, as
early as 6 years of age. Thus, one of the important factors to consider is
the preservation of fertility. These tumors originate from the germ cells
of the ovary. Germ cell tumors account for about 5-7% of all ovarian
cancers(9), 20% of ovarian tumors (25), and account for >60% of tumors
occurring in patients younger than 20 years of age. One-th.ird of the
germ cell tumors diagnosed in patients younger than 20 years of age are
malignant. The most common subtype is the benign cystic teratoma, also
known as dermoid cyst. It is worthy to note that this type of ovarian
tumor accounts for about 25% of all rumors in pregnancies.

Risk factors
This is the most common type of ovarian tumors inyoung women (9, 25).

Subtypes of germ cell ovarian tumors
Germ cell ovarian tumors have 5 different subtypes.
Dermoid cyst (mature cystic teratomas)
Most of these contain hair or sebaceous material, but may also contain
substances derived from all three germ cell layers. These are usually
benign, but may be squamous carcinomas in 1% of the cases.
Dysgerminoma
This subtype comprises about 50% of all germ cell tumors and therefore
is the most common subtype of germ cell tumors. They also tend to form
before the age of 30. They are usually unilateral but are bilateral in about
15% of the cases (2). In this subtype, due to the presence of enlarged
cells, there is an elevation in lactate dehydrogenase (LOH) (2)1evels and
in 5% of the cases cells may produce HCG which may also be elevated
(2, 9). An important aspect of dysgerminoma is that it has the highest
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possibility of spreading to the peritoneal cavity and lymph nodes
compared to other ovarian malignancies (2). There is a recurrence rate of
about 17% after treatment(2).
Yolk sac tumors (endodermal sinus tumors)
This subtype accounts for 25% of germ cell rumors and is the second
most common subtype of germ cell rumors (2). Upon microscopic
examination, these tumors have a distinct reticular pattern and usually
contain acid-schiff (PAS) positive hyaline bodies. As well as papillary
structures. these cells usually contain and secrete AFP (alpha-fetoprotein)
which may be measured in serum. The median age in which these tumors
present is 19 (2). The most common symptoms that patients complain of
are abdominal pain, fever, vaginal bleeding or an abdominal mass (2).
Immature teratoma
This is the third most common subtype and accounts for about 15-20% of
all ovarian germ cell tumors (2). Similar to dermoid cysts, they contain
substances derived from all three germ cell layers (9). The median age at
presentation is 19. This type of rumor usually does not produce any
tumor markers and are almost exclusively unilateral and are stage 1 at
diagnosis (2). The survival rate is highly dependent on the stage of the
disease. TI1ose with grade I have a survival rate of about 93% while those
with stage ID have a survival rate of about 33%. The mode of treatment
is adjuvant chemotherapy as well as surgery (2).
Embryonic carcinomas and choriocarcinomas
Embryonic carcinoma is very rare and is often confused with
Endodermal sinus tumors. 1l1irtccn years is the median age of
presentation and is usually unilateral (2). These tumors usually give a
positive pregnancy test and in 60% of the cases show a hormonal profile
that is consistent with precocious puberty in premenarcheal girls and
abnormal vaginal bleeding in postmenarcheal girls. Choriocarcinomas
are extremely rare and are also associated with an increased HCG level
(2). These subtypes tend to produce HCG, rarely AFP and cause irregular
uterine bleeding (9). The efficacy of treatment using adjuvant
chemotherapy is not known due to the rarity of this tumor. The treatment
regimen is thus usually identical to the Endodermal sinus tumors.
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Juvenile granulosa cell tumors
These tumors often occur in the first two decades of life and in 80% of
the cases, they present with menstrual irregularity or isosexual precocity.
These patients may present with peritonitis, ascites and/or a pelvic mass.
The majority of these tumors are unilateral and thus limited unilateral
salpingo-oophorectomy is usually sufficien1 to confine the disease and
the patient would not require any further therapy.
Germ cell ovarian tumors should be staged after excision using the
International Federation of Gynecologic Oncologists (FIGO).
Stage 1: tumor is confined to the ovaries
IA: tumor growth is limited to one ovary without any malignant
ascites
IB: tumor growth is limited to two ovaries without any malignant
ascites
IC: tumor or stage 1A or 1B but with ascites or ruptured capsules
Stage 2: tumor has spread to the pelvis
2A: metastasis to the fallopian tubes or uterus
2B: both ovaries affected and extended to the pelvis
2C: a tumor of stage 2A or 2B But with ascites
Stage 3: tumor seeds in the abdominal cavity or retroperitoneal
lymph nodes
3A: confined to the pelvis
3B: metastasis to the peritoneal cavity but not >2cm mass
3C: metastasis to the peritoneal cavity but >2cm mass
Stage 4: metastasis into other distant organs
Symptoms
Patients usually present with acute abdominal pain which is likely due to
ovarian torsion, hemorrhage or cyst rupture. There may be vaginal
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bleeding, fever. as well as symptoms of hyperthyroidism or carcinoid
syndrome.

Diagnosis
Diagnosis is done using CT of the abdomen and pelvis as well as an
ultrasound. A physical exam is often used to detect an abdominal and
pelvic mass. Primary amenorrhea, virilization and genital abnormalities
should also be used as diagnostic events. HCG, AFP, CA-125 and LDH
should be measured and monitored.

Other conditions causing similar symptoms
Germ cell ovarian tumors may present with symptoms that are also seen
in appendicitis, ectopic pregnancy and ovarian torsion. Titus, these
conditions should be eliminated prior to making a final diagnosis.
Epithelial ovarian tumors, adrenal tumors and other pelvic masses may
also be behind these symptoms.

Treatment
Due to fertility concerns, radiation is rarely used in germ cell tumors (9).
These types of ovarian tumors are very chemosensitive to platinum-based
therapies (25). Chemotherapy using bleomycin, etoposide, cisplatin (9,
24), actinomycin D and vinc1iscine is sometimes used. Surgery is usually
done in cases where a benign cystic teratoma is the diagnosis, as well as
unilateral salpingo-oophorectomy (2). Staging after surgery is essential in
determining what the next step is going to be (9). Dysgerminoma is
treated by unilateral salpingo-oophorectomy making sure that a frozen
section should be obtained, at the time of the laboratory. to confirm the
diagnosis.
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Follow-up
If there is a significant mass or abnormal HCG, AFP or CA-125, the patient
should be immediately referred to a gynecologic oncologist. Lymph node
metastasis depend onthe histological subtype of the tumor and is indicative of
poor survival (25).

E. MALIGNANT EPITHELIAL OVARIAN TUMORS
Epithelial ovarian cancer is the number one cause of gynecologjcal death
in women and the fifth leading cause of death in women overall (10).
Accounting for about 90% of ovarian cancers, epithelial ovarian tumors
are the most common type of ovarian cancer (6). This type affects mostly
postmenopausal women. The lifetime risk of developing ovarian cancer
in the population is about 1.4%. Ovarian cancer is very rare in the
adolescent age group. About 2.3% of ovarian cancers occur in patients
under 25 years of age. out of which only about 40% were under 19 years
of age (26). In general malignant neoplasms are very rare in the pediatric
and adolescent population (21).

Risk factors
There are several risk factors for developing epithelial ovarian tumors
including early menarche, late age of menopause. no children, infertility
and talc use. Some of the protective factors against epithelial ovarian
tumors include pregnancy, oral contraceptive use and breastfeeding.

Subtypes of epithelial ovarian tumors
All epithelial ovarian tumors should be removed and staged after
excision using the International Federation of Gynecological Oncologists
(FTGO).
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Stage 1: tumor is confined to the ovaries
IA: tumor growth is limited to one ovary without any malignant
ascites
IB: tumor growth is limited to two ovaries without any malignant
ascites
LC: tumor or stage 1A or 1B but with ascites or ruptured capsules
Stage 2: tumor has spread to the pelvis
2A: metastasis to the fallopian tubes or uterus
2B: both ovaries affected and extended to the pelvis
2C: a tumor of stage 2A or 2B but with ascites
Stage 3: tumor seeds in the abdominal cavity or retroperitoneal
lymph nodes
3A: confined to the pelvis
3B: metastasis to the peritoneal cavity but not >2cm mass
3C: metastasis to the peritoneal cavity hut >2cm mass (this is the
most common stage of diagnosis)
Stage 4: metastasis into other distant organs
Upon histological analysis of the excised tumor, epithelial ovarian cancer
is subtyped to mucinous, serous, endometrioid, clear cell, transitional,
small cell, malignant milled mesodermal, and unclassified (1).

Symptoms
Most of the time, patients are asymptomatic until the advanced stages are
reached. In advanced stages, there is often abdominal fullness and pain
(5, 9), urinary frequency, abnormal vaginal bleeding and pelvic pressure.

Diagnosis
A physical exam including a pelvic and abdominal exam should be done
to detect any masses. Pleural effusions may be noted by decreased breath
sounds and lymph nodes should be examined for any palpable masses.
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CA-125 is often used to monitor and assess response to therapy, but
should not be used as a diagnostic tool in women who are at low 1isk or
asymptomatic (9). 80-85% of patients with advanced ovarian cancer have
elevated CA· 125 (3). A complete blood count and an abnormal metabolic
panel may be used as an indicator for epithelial ovarian cancer.
Unfortunately, there is no definitive test for early diagnosis. Imaging
techniques such as ultrasound is most commonly used to detect ovarian
masses with ascites or free pelvic fluid. A chest radiograph is sometimes
performed to detect the presence of nodules. A CT scan often shows a
pelvic or abdominal mass (9).

Other conditions causing similar symptoms
Tuba-ovarian abscess or other infections such as appendicitis may
present with similar symptoms. An elevated CA-125 or the presence of
ascites may be detected in patients with Iiver disease. In addition, several
other tumors such as borderline, malignant and nonmalignant tumors
may also have similar symptoms to epithelial ovarian tumors.

Treatment
A laparotomy must be performed and the tumor staged. Maximum
cytoreductive surgery is often essential for a better prognosis if cancer is
found. Peritoneal washings should be performed and typed. Also, total
abdominal hysterectomy is favorable as well as samples from the
diaphragm to detect any metastasis (9). Adjuvant chemotherapy is
standard in treating ovarian cancer patients. Standard chemotherapeutic
agents used include a platinum agent such as cisplatin and taxanes such
as paclitaxel. For patients that develop recurrent disease, several other
drugs may be used but are only beneficial in 10-25% of the cases and are
not curative (9).
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Follow-up
Patients should be referred to a gynecologic oncologist if there is a high
likelihood of ovarian cancer. If diagnosed at early stages. the prognosis is
much better. In fact, the 5-year survival rate at stage I is 90% whereas at
advanced stages, it is about 20%. CA-125 should be used to monitor the
patient on a regular basis every 3 months. Most reoccurrences of cancer
occur during the first 2 years after treatment (9).

F. VIRILIZING OVARIAN TUMORS
This type of ovarian tumor is extremely rare. In fact, it accounts for about
0.5% of all primary ovarian neoplasms. This type of tumor may occur at
any age but mostly in the 2nd and 3rd decade of life. The hallmark of this
tumor type is the production of androgenic steroid hormones. There arc
several substances that are released by this tumor that may often be used
as markers (9). In the pediatric and adolescent population, the presence
o f a virilizing tumor should be taken into consideration when prepubertal
girls present to the clinic with precocious puberty. This tumor develops
from the cells that surround the oocytes (cumulus cells which are
composed of granulosa cells). This tumor may be benign or malignant
but is almost always firm, solid and have a smooth surface. Most of these
tumors have low grade histology (9).

Risk factors
There are no known risk factors to date (9).

Subtypes of virilizing ovarian tumors
All epithelial ovarian tumors should be removed and staged after
excision using the International Federation of Gynecological Oncologists
(FIGO).
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Stage 1: tumor is confined to the ovaries
1A: tumor growth is limited to one ovary without any malignant
ascites
1B: tumor growth is limited to two ovaries without any malignant
ascites
1C: tumor or stage 1A or l B but with ascites or ruptured capsules
Stage 2: tumor has spread to the pelvis
2A: metastasis to the fallopian tubes or uterus
2B: both ovaries affected and extended to the pelvis
2C: a tumor of stage 2A or 2B but with ascites
Stage 3: tumor seeds in the abdominal cavity or retroperitoneal
lymph nodes
3A: confined to the pelvis
38: metastasis to the peritoneal cavity but not >2cm mass
3C: metastasis to the peritoneal cavity but >2cm mass (this is the
most common stage of diagnosis)
Stage 4: metastasis into other distant organs
There are mainly three subtypes of virilizing ovarian tumors
•
•
•

Sertoli-stromal cell tumors: These tumors may appear as well,
poor or intermediate in differentiation.
Gynandroblastoma
Steroid (lipid) cell tumors: These include stromal luteoma, lydig
cell tumor or unclassified.

Symptoms

The chief complaint is usually abdominal pain and an increase in
abdominal girth.
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Diagnosis
There are certain findings during the physical exam that may help in the
diagnosis of virilizing ovarian tumor such as a palpable adnexal mass,
breast atrophy, hirsutism, deep voice, male pattern baldness and acne on
the face or back. Certain lab tests such as inhibin, testosterone, AFP,
DHEA . 17-hyclroxyprogesterone and androstenedione may be performed
to help confirm the diagnosis. A pelvic ultrasound and a CT scan of the
chest and abdomen are also preferable (9).

Other conditions causing similar symptoms
PCOS and Cushing syndrome often present with similar symptoms and
lab results. Thus, it is necessary to eliminate any suspicion regarding the
presence of a virilizing tumor. Steroid use may also cause similar lab
results (9).

T1·eatment
Surgery is the main mode of treatment. Chemotherapy is often used to
treat metastatic disease such as cisplatin and bleomycin (9).

Follow-up
Patients will need to visit a gynecologist every 2-4 weeks and a routine
physical examination as well as testosterone levels every 2-3 months
afterwards (9).
RECENT ADVANCES IN TUMOR BIOMARKERS
There have been several reports regarding potential new ovarian tumor
diagnostic markers. One of the most researched in the literature is
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Lysophosphatidic acid (LPA) receptor. LPA receptors are G-protein
coupled receptors. Two receptor subtypes, namely LPA 2 and 3 have
been shown to be over expressed in most ovarian cancer cells. There are
several studies unde1way trying to decipher the role of LPA receptors in
ovarian tumor progression and are showing promise to its use (27).

OTHER CONCERNS
Due to the rigorous treatment measures and chemotherapy, adolescents
often struggle with depression and poor body image even after the tumor
has been removed. Thus, it is of utmost impo1tance to take into account
the psychological impact of the presence and treatment of ovarian
rumors. In addition, fertility issues should be discussed extensively with
the adolescent as well as their parents before any surgery is performed. It
has been previously reported that there is a 15% decrease in fertility in
survivors of pediatric gynecological cancers (28 ).

SUMMARY OF LAB TESTS HELPFUL TO THE DIAGNOSIS
OF OVARIAN CANCERS
CA 125: usually elevated in epithelial tumors, and rarely in teratomas. It
should not be used in asymptomatic patients
AFP: usually elevated in germ cell tumors, embryonic carcinoma,
endodermal tumors and rarely but may be seen in polyembryoma and
immature teratoma.
HCG: usually found in patients with choriocarcinoma, embryonic
and germ cellrumors, and rarely in dysgerminoma
Carcinoembryonic antigen and LDH: this is usually seen in germ cell
tumors and dysgerminoma
Estradiol: thecomas and adult granulose cell rumors
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CONCLUSION
Ovarian tumors are uncommon in the child and adolescent population,
but given that cancer is a leading cause of death even in this age group it
is important for the general practice physician to be aware of the signs
and symptoms. These can include abdominal pain, increased abdominal
girth, a palpable mass on pelvic or abdominal exam, nausea and
vomiting, decreased appetite, weight loss, constipation, back pain. leg
cramps, dyspareunia, urinary symptoms, abnormal uterine bleeding, and
ascites, to name a few. The types of gynecological tumors seen in adults
are also seen in children except in differing frequencies. The most
common type of ovarian tumor in children is the germ cell tumor, of
which there are several subtypes including dermoid cysts,
dysgerminoma, yolk sac tumor, immature teratomas, and embryonal
carcinomas. Each requires different laboratory workups and equally
varied treatment plans. Functional cysts are typically benign in nature
and can resolve on their own. Their etiology depends on the stage of the
female cycle in which they occur. Other benign ovarian rumors such as
endometriomas, cystic teratomas, and epithelial tumors along with
borderline ovarian tumors, which may progress to a malignant stage, are
rare in children and adolescents. Given the low probability of malignancy
of these rumors, but poor prognosis if discovered at an advanced stage, it
is important for the general practitioner and pediatrician to keep a high
level of suspicion. Given the symptoms for ovarian tumors are common
complaints seen daily in the outpatient setting, these can be difficult to
differentiate from more common diagnoses, but is the reason to keep in
mind other aspects of the child and their overall growth and
development. Body image and fertility are significant issues to the
adolescent female, therefore side effects as well as benefits of treatment
sbould be given adequate discussion with the physician, parents and
patient prior to initiation of treatment.

Benign

Benign, borderline,
and malignant
potential
Benign
Borderline

Endometrioma

Epithelial
Serous
Mucinous
Benign Cystic Teratoma
Borderline
Serous
Mucinous
Germ Cell
Dermoid Cyst
Dysgerminoma
Yolk Sac

Benign or malignant
depending on the type

Benign

Benign Vs
Malignant

Functional Cysts
Follicular
Luteal
Pregnancy luteoma

Name

All three germ
cell layers

Germ cell

Exaggerated
ovarian function,
anovulation,
follicular or luteal
origin
Often
accompanies
endometriosis

Pathology

Table 1. Summary of ovarian tumors

Chemotherapy and surgery where
necessary

Cystectomy
Excision ± hysterectomy in
acceptable circumstances

As above

Observation
Possible role of combination
contraceptive pills
Laparoscopy evaluation in case of
rupture
As above

Treatment Recommendations

lmmature teratoma

Unclassified

Lydig cell

Stromal Luteoma

Steroid (lipid) cell

Gynaodroblastoina

Sertoli cell

Virilizing

Malignant Epithelial

Choriocarcinoma

Embryonal Carcinoma
Malignam
Benign or malignant
Epithelial

Surgery and chemotherapy
As above
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